Sign in to view content

AAV-RPGR Gene Therapy for RPGR-Associated X-Linked Retinitis Pigmentosa: 6-month Results From a Phase 1/2 Clinical Trial

Michel Michaelides, BSc, MB BS, MD(Res), FRCOphth, FACS

Video
Published 2020

Related

The Good, the Bad, and the Best of Wnt Signaling
Kimberly A. Drenser, MD
Annual Meeting Talks
2019
3-Year Update for the Phase 3 Voretigene Neparvovecrzyl Study in Biallelic RPE65 Mutation–Associated Inherited Retinal Disease
Stephen R. Russell, MD
Updates from the Field
2018
Episode 207: January 2020 Retinal Physician Preview: EHR Integration, Swept-Source OCTA, Intraoperative OCT, Optogenetics
Jayanth Sridhar, MD
Member Podcasts
2020

Category: Hereditary Retinal Disease & Genetics

See more